...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Annual Financial Reporting

The 2023 audited Financial Statement for RVX should be due at month's end, March 31, 2024.

Anxious to see how much financial support RVX is getting from Zenith to keep the light on. 

Zenith's 3rd quarter filings (January 31, 2024) are overdue.

 

Koo

1
Mar 22, 2024 03:10PM
2
Mar 22, 2024 03:46PM
1
Mar 22, 2024 04:17PM
1
Mar 22, 2024 04:57PM
1
Mar 22, 2024 05:43PM
2
Mar 23, 2024 10:17AM
1
Mar 23, 2024 06:16PM
1
Mar 23, 2024 07:48PM
3
Mar 23, 2024 08:04PM
1
Mar 23, 2024 08:21PM
Share
New Message
Please login to post a reply